Partial protection of verapamil against gentamicin nephrotoxicity in rats

Authors

  • Khulood S. Al-Kaaby 7th of April University, Medicine College, pharmacology department, Surman, Libya
  • Saad M. Arif 7th of April University, Medicine College, Microbiology department, Surman, Libya.
  • Hussain Ahmed Al-Sheriff Mustanssiryah University, Dean of College Of Pharmacy, Baghdad, Iraq

DOI:

https://doi.org/10.32947/ajps.v7i1.326

Keywords:

Acute renal failure, Plasma creatinine, blood urea nitrogen, calcium channel blockers, Endothelium derived relaxing factor

Abstract

A number of male rats (40) were used to test the protective efficacy of verapamil a calcium channel blocker (CCB) against gentamicin nephrotoxicity.
They were divided into four groups: group-1 control, giving only water, group- 2, they were administered gentamicin IP 80 mg/Kg, group-3, administered
verapamil orally 10 mg/Kg and group-4 administered gentamicin and verapamil at the same time. The period of study was 10 days.
Nephrotoxicity was induced by using gentamicin for 7 days; this was evidenced by marked elevation in blood urea nitrogen (BUN) andplasma creatinine (Pcr) when compared with control. BUN increased from 20±1.4 to 205±7 and Pcr from 0.75±0.08 to 4.2±0.3 mg/100 ml). Coadministration of verapamil with gentamicin decreased the rise in BUN and Pcr, their values reached to 90±13 and 1.5±0.9 mg/100 ml respectively.
Our data suggest that supplementation of verapamil decreased the severity of acute renal failure (ARF) in rats, this supports previous studies in which CCBs offer renoprotection in ARF, the exact mechanism of this protection need further study.

Downloads

Published

2010-06-01

How to Cite

Al-Kaaby, K. S., Arif, S. M., & Al-Sheriff, H. A. (2010). Partial protection of verapamil against gentamicin nephrotoxicity in rats. Al Mustansiriyah Journal of Pharmaceutical Sciences, 7(1), 137–144. https://doi.org/10.32947/ajps.v7i1.326

Issue

Vol. 7 No. 1 (2010): volume 7,Issue 1. 2010

Section

Articles

License

AJPS is an open-access journal that all contents are free of charge. Articles of this journal are licensed under the terms of the Creative Commons Attribution International Public License CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/legalcode) that licensees are unrestrictly allowed to search, download, share, distribute, print, or link to the full texts of the articles, crawl them for indexing and reproduce any medium of the articles provided that they give the author(s) proper credits (citation). The journal allows the author(s) to retain the copyright of their published article.
Creative Commons-Attribution (BY) 
Crossref
Scopus
Google Scholar
Europe PMC